A regulatory system for approving new drugs is certainly necessary, says In the Pipeline's Derek Lowe, but is it the right system? Lowe references an article at BioCentury that suggests an adaptive system instead of one that makes binary decisions. In other words, Lowe says, the idea is to set things up so that data can be generated quickly, that decisions can be made on that data, and then modified when additional findings come out.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.